ArticleFrontiers in endocrinology2026
An explainable predictive machine learning model of osteopenia for perimenopausal women based on clinical data: a retrospective single-center study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Osteoporosis is increasingly prevalent, yet early detection remains difficult. This study aimed to develop a machine learning (ML)-based model for identifying individuals at risk of osteopenia using clinical data. Methods: Female participants who were aged 45 years and above with complete femoral neck BMD data were included. A total of 1,108 participants were divided into training (70%) and test (30%) datasets. Various ML-based algorithms (random forest (RF), least absolute shrinkage and selection operator (LASSO), gradient boosting decision tree (GBDT) were used to identify key predictors of osteopenia, including clinical and biochemical markers. Model performance was evaluated based on area under the curve (AUC), accuracy, sensitivity, specificity, precision, and F1 score, with SHAP analysis used for feature importance. Results: Totally, 17 predictors were identified, with RF demonstrating the best performance (AUC: 0.978 in training, 0.933 in validation datasets). Key predictors of osteopenia included menopause, age, procollagen type I N-terminal propeptide (PINP), beta-crosslaps (β-CTX), height, and estimated glomerular filtration rate (eGFR). RF outperformed other models in both identify accuracy and clinical utility, with an AUC of 0.90 and AUPR of 0.93 for the top six features. A web-based calculator was developed for clinical use. Conclusion: The RF model can effectively identify osteopenia and could improve early detection of osteoporosis. This model, with its integration into clinical practice, has the potential to enhance patient outcomes and reduce osteoporosis-related risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.